GEODE CAPITAL MANAGEMENT, LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in ARQT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$78,199,733
+$6,452,325 QoQ
Shares Held
2,982,446
-2.1% QoQ
Ownership
2.37%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 271 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ARQT ranks #60 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ARQT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,199,733 | 2,982,446 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $71,747,408 | 3,045,306 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $79,956,035 | 2,753,307 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $49,131,865 | 2,606,465 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $36,207,588 | 2,582,567 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $39,834,250 | 2,546,947 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $34,445,128 | 2,472,730 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $22,972,283 | 2,470,138 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $22,517,810 | 2,421,270 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $19,536,901 | 1,971,433 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,631,792 | 1,743,589 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,511,493 | 1,037,946 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,933,869 | 937,447 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,892,037 | 808,367 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,531,331 | 779,144 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,031,402 | 734,244 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,118,272 | 568,666 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,810,678 | 509,381 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,148,994 | 489,344 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $11,678,745 | 488,855 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,961,849 | 474,967 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,490,758 | 431,758 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $9,512,215 | 338,152 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,263,850 | 247,913 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,604,402 | 152,262 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,799,324 | 60,380 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||